Richard O. Day

35.3k total citations · 6 hit papers
615 papers, 25.1k citations indexed

About

Richard O. Day is a scholar working on Pharmacology, Rheumatology and Surgery. According to data from OpenAlex, Richard O. Day has authored 615 papers receiving a total of 25.1k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Pharmacology, 84 papers in Rheumatology and 79 papers in Surgery. Recurrent topics in Richard O. Day's work include Inflammatory mediators and NSAID effects (67 papers), Gout, Hyperuricemia, Uric Acid (60 papers) and Pharmaceutical Practices and Patient Outcomes (54 papers). Richard O. Day is often cited by papers focused on Inflammatory mediators and NSAID effects (67 papers), Gout, Hyperuricemia, Uric Acid (60 papers) and Pharmaceutical Practices and Patient Outcomes (54 papers). Richard O. Day collaborates with scholars based in Australia, United States and United Kingdom. Richard O. Day's co-authors include M. Fuller, Victor A. Schmidt, Garry G. Graham, Andrew J. McLachlan, Kenneth M. Williams, Peter Brooks, Kenneth M. Williams, Johanna Westbrook, Loren Laine and Christopher J. Hawkey and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Richard O. Day

592 papers receiving 23.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

2000 3.0k citations Claire Bombardier, Loren Laine et al. New England Journal of Medicine profile →
Hysteresis properties of titanomagnetites: Grain-size and compositional dependence

1977 2.5k citations Richard O. Day et al. profile →
Clinical Pharmacokinetics of Metformin

2011 979 citations Garry G. Graham, Richard O. Day et al. Clinical Pharmacokinetics profile →
Nonsteroidal Antiinflammatory Drugs — Differences and Similarities

1991 626 citations Richard O. Day et al. New England Journal of Medicine profile →
The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings

2013 450 citations Garry G. Graham, Richard O. Day et al. profile →
Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials

2015 383 citations Richard O. Day, Andrew J. McLachlan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard O. Day Australia	70	7.3k	5.7k	3.4k	2.8k	2.6k	615	25.1k
Yuichi Sugiyama Japan	99	3.1k 0.4×	7.8k 1.4×	4.3k 1.3×	11.2k 4.0×	934 0.4×	831	40.4k
Hua Wang China	95	1.7k 0.2×	13.6k 2.4×	3.0k 0.9×	1.4k 0.5×	1.1k 0.4×	1.1k	39.3k
T. J. Peters United Kingdom	98	1.5k 0.2×	4.0k 0.7×	4.7k 1.4×	460 0.2×	4.0k 1.5×	1.1k	40.4k
Peter J.H. Jones Canada	77	926 0.1×	5.1k 0.9×	7.9k 2.3×	599 0.2×	269 0.1×	487	24.1k
Elizabeth J. Phillips United States	69	6.2k 0.8×	2.1k 0.4×	468 0.1×	1.2k 0.4×	1.8k 0.7×	313	21.5k
Wei Wang China	82	819 0.1×	10.4k 1.8×	3.6k 1.1×	463 0.2×	1.4k 0.5×	1.6k	36.6k
E. Ernst United States	70	871 0.1×	821 0.1×	846 0.3×	386 0.1×	230 0.1×	426	17.5k
Daniel J. Rader United States	116	2.3k 0.3×	13.3k 2.3×	26.2k 7.8×	654 0.2×	1.5k 0.6×	774	58.5k
G. Wilkinson United States	93	2.5k 0.3×	3.8k 0.7×	1.6k 0.5×	9.0k 3.3×	201 0.1×	403	35.3k
Michael S. Roberts Australia	84	3.2k 0.4×	4.4k 0.8×	1.4k 0.4×	1.6k 0.6×	369 0.1×	693	28.3k

Countries citing papers authored by Richard O. Day

Since Specialization

Citations

This map shows the geographic impact of Richard O. Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard O. Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard O. Day more than expected).

Fields of papers citing papers by Richard O. Day

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard O. Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard O. Day. The network helps show where Richard O. Day may publish in the future.

Co-authorship network of co-authors of Richard O. Day

This figure shows the co-authorship network connecting the top 25 collaborators of Richard O. Day. A scholar is included among the top collaborators of Richard O. Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard O. Day. Richard O. Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

White‐Koning, Mélanie, Daniel F. B. Wright, Dyfrig Hughes, et al.. (2024). Relative Forgiveness of Different Allopurinol Implementation Patterns in People with Gout and their Impact on Clinical Outcomes: a Simulation Study. Clinical Pharmacokinetics. 64(1). 93–105. 1 indexed citations

Cashin, Aidan G, et al.. (2024). Barriers and enablers to exercise adherence in people with nonspecific chronic low back pain: a systematic review of qualitative evidence. Pain. 165(10). 2200–2214. 14 indexed citations

Li, Ling, Jannah Baker, Wu Yi Zheng, et al.. (2024). Drug–Drug Interactions and Actual Harm to Hospitalized Patients: A Multicentre Study Examining the Prevalence Pre- and Post-Electronic Medication System Implementation. Drug Safety. 47(6). 557–569. 5 indexed citations

Thorlund, Jonas Bloch, Milena Simić, Kenneth Pihl, et al.. (2022). Similar Effects of Exercise Therapy, Nonsteroidal Anti-inflammatory Drugs, and Opioids for Knee Osteoarthritis Pain: A Systematic Review with Network Meta-analysis. Journal of Orthopaedic and Sports Physical Therapy. 52(4). 207–216. 36 indexed citations

Carland, Jane E., Deborah Debono, Melissa Baysari, et al.. (2021). Accuracy of documented administration times for intravenous antimicrobial drugs and impact on dosing decisions. British Journal of Clinical Pharmacology. 87(11). 4273–4282. 16 indexed citations

Harper, Ashton, Vineetha Vijayakumar, Arthur C. Ouwehand, et al.. (2021). Viral Infections, the Microbiome, and Probiotics. Frontiers in Cellular and Infection Microbiology. 10. 596166–596166. 112 indexed citations

Westbrook, Johanna, Ling Li, Magdalena Z. Raban, et al.. (2020). Associations between double-checking and medication administration errors: a direct observational study of paediatric inpatients. BMJ Quality & Safety. 30(4). 320–330. 28 indexed citations

Nguyen, Amy, et al.. (2020). Australian patient perspectives on the impact of gout. International Journal of Rheumatic Diseases. 23(10). 1372–1378. 9 indexed citations

Darley, D.R., et al.. (2019). Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection. European Journal of Clinical Pharmacology. 75(7). 879–888. 5 indexed citations

10.

Nguyen, Amy, et al.. (2018). mHealth App Patient Testing and Review of Educational Materials Designed for Self-Management of Gout Patients: Descriptive Qualitative Studies. JMIR mhealth and uhealth. 6(10). e182–e182. 20 indexed citations

11.

Lyell, David, Farah Magrabi, Magdalena Z. Raban, et al.. (2017). Automation bias in electronic prescribing. BMC Medical Informatics and Decision Making. 17(1). 28–28. 54 indexed citations

12.

McKinney, Cushla, Lisa K. Stamp, Nicola Dalbeth, et al.. (2015). Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout. Arthritis Research & Therapy. 17(1). 288–288. 52 indexed citations

13.

Martinello, Marianne, Maryam Alavi, Kenneth M. Williams, et al.. (2015). The Impact of Ribavirin Plasma Concentration on the Efficacy of the Interferon-Sparing Regimen, Sofosbuvir and Ribavirin. Antiviral Therapy. 21(2). 127–132. 3 indexed citations

14.

Baysari, Melissa, et al.. (2015). Identifying effective computerized strategies to prevent drug–drug interactions in hospital: A user-centered approach. International Journal of Medical Informatics. 84(8). 595–600. 11 indexed citations

15.

Stocker, Sophie L., Andrew J. McLachlan, Radojka M. Savić, et al.. (2012). The pharmacokinetics of oxypurinol in people with gout. British Journal of Clinical Pharmacology. 74(3). 477–489. 25 indexed citations

16.

Ghinea, Narcyz, Wendy Lipworth, Ian Kerridge, & Richard O. Day. (2012). No evidence or no alternative? Taking responsibility for off‐label prescribing. Internal Medicine Journal. 42(3). 247–251. 7 indexed citations

17.

Day, Richard O., et al.. (2009). Are specialist physicians missing out on the e‐Health boat?. Internal Medicine Journal. 39(10). 655–661. 3 indexed citations

18.

Bombardier, Claire, Loren Laine, Alise Reicin, et al.. (2000). Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis. New England Journal of Medicine. 343(21). 1520–1528. 2956 indexed citations breakdown →

19.

Donnelly, Richard, et al.. (1997). Effects of Budesonide and Fluticasone on 24-Hour Plasma Cortisol. American Journal of Respiratory and Critical Care Medicine. 156(6). 1746–1751. 57 indexed citations

20.

Day, Richard O., et al.. (1954). INTELLIGENCE QUOTIENTS OF CHILDREN RECOVERED FROM ERYTHROBLASTOSIS FETALIS SINCE THE INTRODUCTION OF EXCHANGE TRANSFUSION. PEDIATRICS. 13(4). 333–338. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact